TSX Venture Exchange: NVC
VANCOUVER, June 14, 2012 /CNW/ - Neovasc Inc. (TSXV: NVC), a developer of novel technologies to treat vascular
disease, today announced that the company will present at the Bloom
Burton & Co. Healthcare Investor Conference on June 21, 2012 at 9:30 am
EDT. The conference will be held at the Toronto Board of Trade in
Toronto, Canada. Neovasc management will provide an overview of recent
A copy of the corporate presentation that includes the material Neovasc
will be presenting will be available on the Neovasc website at www.neovasc.com/investors/presentations.php.
About the Bloom Burton & Co. Healthcare Investor Conference
Bloom Burton & Co. is Canada's largest and most active
healthcare-specialized investment banking group. The Healthcare
Investor Conference brings together U.S., Canadian and European
investors who are interested in the latest developments in the Canadian
healthcare sector. Attendees will have an opportunity to obtain
corporate updates from the premier Canadian public and private
companies through presentations and break-out Q&A sessions. For more
information, visit http://bloomburton.com/conference/index.php.
About Neovasc Inc.
Neovasc Inc. is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc Reducer™
for the treatment of refractory angina, the Tiara™ technology in
development for the transcatheter treatment of mitral valve disease and
a line of advanced biological tissue products that are used as key
components in a variety of third-party medical products, such as
vascular surgical patches and transcatheter heart valves. For more
information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
For further information:
U.S. media & investor contact:
BLL Partners, LLC